117 related articles for article (PubMed ID: 21725161)
61. Expression of Phosphorylated AMP-Activated Protein Kinase Predicts Response to Transarterial Chemoembolization in Postoperative Cases of Hepatocellular Carcinoma.
Zheng LY; Wu L; Lu J; Zou DJ; Huang Q
Medicine (Baltimore); 2016 Mar; 95(11):e2908. PubMed ID: 26986101
[TBL] [Abstract][Full Text] [Related]
62. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
63. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
[TBL] [Abstract][Full Text] [Related]
64. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
65. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
[TBL] [Abstract][Full Text] [Related]
66. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
67. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
68. Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype.
Lin Y; Lin G; Fang W; Zhu H; Chu K
Med Oncol; 2014 Dec; 31(12):327. PubMed ID: 25412936
[TBL] [Abstract][Full Text] [Related]
69. UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Xu H; Yu H; Zhang X; Shen X; Zhang K; Sheng H; Dai S; Gao H
Int J Clin Exp Pathol; 2013; 6(4):711-7. PubMed ID: 23573318
[TBL] [Abstract][Full Text] [Related]
70. SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma.
Yang SF; Yeh YT; Wang SN; Hung SC; Chen WT; Huang CH; Chai CY
Pathology; 2008 Oct; 40(6):558-63. PubMed ID: 18752121
[TBL] [Abstract][Full Text] [Related]
71. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
Koegl M; Courtneidge SA; Superti-Furga G
Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
[TBL] [Abstract][Full Text] [Related]
72. Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma.
Zhang Y; Deng ZS; Liao MM; Wang N; Zhang XQ; Yu HY; Zhang YD
Pathol Oncol Res; 2012 Oct; 18(4):911-6. PubMed ID: 22434316
[TBL] [Abstract][Full Text] [Related]
73. Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity.
Donella-Deana A; Cesaro L; Ruzzene M; Brunati AM; Marin O; Pinna LA
Biochemistry; 1998 Feb; 37(5):1438-46. PubMed ID: 9477973
[TBL] [Abstract][Full Text] [Related]
74. Decreased expression of LKB1 correlates with poor prognosis in hepatocellular carcinoma patients undergoing hepatectomy.
Huang YH; Chen ZK; Huang KT; Li P; He B; Guo X; Zhong JQ; Zhang QY; Shi HQ; Song QT; Yu ZP; Shan YF
Asian Pac J Cancer Prev; 2013; 14(3):1985-8. PubMed ID: 23679304
[TBL] [Abstract][Full Text] [Related]
75. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
76. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
Liu B; Zhang J; Huang C; Liu H
PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
[TBL] [Abstract][Full Text] [Related]
77. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
[TBL] [Abstract][Full Text] [Related]
78. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
[TBL] [Abstract][Full Text] [Related]
79. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
Zhang Z; Meng G; Wang L; Ma Y; Guan Z
Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
[TBL] [Abstract][Full Text] [Related]
80. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Wang Y; Huang Q; Deng T; Li BH; Ren XQ
Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
